COVID-19 vaccine

Thermal Custom Packaging Introduces Long-Lasting Alternative for Cold Chain Packaging, Available for Distributors and Individuals Alike

Retrieved on: 
Tuesday, May 17, 2022
RNA transfection, Blood, COVID-19 vaccine, Environment, Climate, Vaccine, Solution, Transport, COVID-19, Dry ice, Ice, Hospital, Technology, Temperature, Hard-shell taco, TCP, PCM, Laboratory, CEO, Food preservation, Pharmaceutical industry

Ice Buddy was made for active lifestyles, enabling consumers to keep contents cold all day without stress or mess.

Key Points: 
  • Ice Buddy was made for active lifestyles, enabling consumers to keep contents cold all day without stress or mess.
  • The hard-shell construction makes the Ice Buddy tough, durable and rugged, yet kind to the environment.
  • "TCP has been developing and selling insulated totes and non- toxic Phase Change Material (PCM) Freezer packs since 2008," shared Founder and CEO of Thermal Custom Packaging, Dr. Clifford Glade.
  • Thermal Custom Packaging (TCP) is a medical product manufacturerspecializing in cold-chain transport solutions, insulated containers (totes), and the chemical reactions that maintain them.

Humana’s CenterWell Senior Primary Care and Welsh, Carson, Anderson & Stowe Announce Second Joint Venture to Develop and Operate Value-Based Primary Care Clinics for Medicare Patients

Retrieved on: 
Monday, May 16, 2022
Seniors, Insurance, Managed Care, General Health, Health, Hospitals, Professional Services, Consumer, U.S. Securities and Exchange Commission, Form, IPA, Government, Home health, Mortality, Welsh, Carson, Anderson & Stowe, Gaps, Adoption, Private Securities Litigation Reform Act, Movement, SEC, Mark (given name), Physician, News, Nursing, Quality of life, Judgement, JV, Family, MA, Failure, Marketing, Pharmacy, Medicare Advantage, Information, Lifting, Conviva, Star, NYSE, CMS, General partnership, Multimedia, Vaccine, Coronavirus, Health, COVID-19 testing, Partnership, WCAS, Phrase, Security (finance), Risk, History, Population, Primary care, COVID-19 vaccine, Patient, Information technology, Privacy, Home, Compliance, Health status of White Americans, Hospital, Pharmaceutical industry, Public relations, Medicine, Health insurance, Risk management, Insurance, Bank, Financial adviser, Humana, COVID-19, Medicare

Humana Inc.s (NYSE: HUM) CenterWell Senior Primary Care and Welsh, Carson, Anderson & Stowe (WCAS) have established a second joint venture (JV) to further expand access to value-based primary care clinics for Medicare patients.

Key Points: 
  • Humana Inc.s (NYSE: HUM) CenterWell Senior Primary Care and Welsh, Carson, Anderson & Stowe (WCAS) have established a second joint venture (JV) to further expand access to value-based primary care clinics for Medicare patients.
  • All de novo clinics developed through the Humana-WCAS joint ventures will be managed and operated under Humanas CenterWell Senior Primary Care brand.
  • Physicians and patients alike are coming to recognize the many advantages of our unique, senior-focused primary care model, said Rene Buckingham, President of Humanas Primary Care Organization which operates both CenterWell Senior Primary Care and Conviva Care Centers.
  • Under the new JV agreement, CenterWell Senior Primary Care will receive a management fee, including performance-based incentives, for the management of all joint venture clinics.

Takeda Delivers Strong FY2021 Results; Continued Growth Momentum Expected in FY2022

Retrieved on: 
Wednesday, May 11, 2022
Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Infectious Diseases, Genetics, COVID-19, Acceleration, Investment, Mission statement, Projection, EBITDA, U.S. Securities and Exchange Commission, JPY, International Financial Reporting Standards, Safety, FX, Patient, Federal Reserve Bank, Review, Acquisition, International, Noon, Annual report, Advertising, Federal Reserve Bank of New York, Hematology, R, IFRS, Quality of life, Income, COVID-19 vaccine, Vaccine, Sale, Takeda Pharmaceutical Company, Growth, Translation, Risk management, Pharmaceutical industry, Takeda, Neuroscience, Gastroenterology

Core operating profit is expected to reach 1.1 trillion JPY, mainly driven by business momentum.

Key Points: 
  • Core operating profit is expected to reach 1.1 trillion JPY, mainly driven by business momentum.
  • The FY2022 reported forecast and management guidance include approximately 50.0 billion JPY revenue contribution from COVID-19 vaccines.
  • Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI).
  • In this press release, Takeda is sometimes used for convenience where references are made to Takeda and its subsidiaries in general.

EpicentRx Announces Oral and Poster Presentations at the 2022 American Thoracic Society (ATS) Respiratory Innovation Summit

Retrieved on: 
Tuesday, May 10, 2022
Washington Marriott Marquis, Marriott Marquis, ADAPT, FC, Capsid, American Thoracic Society, CA, ATS, Poster, Patient, Doctor of Philosophy, Universal, Cancer, MD, Tissue, Quality of life, Potyvirus, Disease, COVID-19 vaccine, Inflammation, Multimedia, Pharmaceutical industry, Vaccine

The presentation entitled "Inflammation and Immunology: Feature Company Showcase" will include EpicentRx Tony Reid, MD, PhD, Chief Executive Officer, and take place on Saturday, May 14 from 11:00 am 11:30 am PT.

Key Points: 
  • The presentation entitled "Inflammation and Immunology: Feature Company Showcase" will include EpicentRx Tony Reid, MD, PhD, Chief Executive Officer, and take place on Saturday, May 14 from 11:00 am 11:30 am PT.
  • N-VAX incorporates the viral nucleocapsid (N) protein in the same human adenovirus serotype 5 platform, hAd5, that is used for AdAPT-001.
  • RRx-001 leads EpicentRx's CyNRGY platform as a first-in-class investigational treatment sourced from an exclusively licensed portfolio of aerospace-derived small molecules.
  • With two platforms, CyNRGY and AdAPT, EpicentRx has developed novel therapies and drug delivery devices with emphasis on not just treating the disease but improving quality of life.

ABBVIE INC. (NYSE: ABBV) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against AbbVie Inc. (NYSE: ABBV)

Retrieved on: 
Tuesday, May 10, 2022
Janus, COVID-19, Investment, Eli Lilly and Company, Ulcerative colitis, The Legal 500, GLOBE, NEW, District court, Securities Exchange Act of 1934, NYSE, Food, Safety, Lists of action films, Atopic dermatitis, Company, ABBV, Risk, Pfizer, FDA, Cancer, Labour government, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Enzyme, Court, Advertising, Lists of schools in England, RA, COVID-19 vaccine, Ankylosing spondylitis, JAK, News, Baricitinib, Rheumatoid arthritis, Biosimilar, Tobacco, Pharmaceutical industry, Animal, Security (finance), Tofacitinib, Upadacitinib, AbbVie

NEW YORK, May 10, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of AbbVie Inc. (“AbbVie” or the “Company”) (NYSE: ABBV) between April 30, 2021 and August 31, 2021, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Northern District of Illinois and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Northern District of Illinois and alleges violations of the Securities Exchange Act of 1934.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Ford Foundation: frontline organizations and private/public partnerships hold keys to global COVID-19 recovery

Retrieved on: 
Monday, May 9, 2022
People, COVID-19, Globe, Policy, Thought, Ford Motor Company, Foundation (nonprofit), Democracy, Society, NEW, Ford Foundation, Playbook, COVID, Partnership, Organization, Internet, Climate change, Indigenous peoples, Institute, Dislocated worker funding, Vaccine, Pandemic, COVID-19 vaccine, Klang Valley Integrated Transit System, View, Life, Solution, Technology, Ownership, Global Initiative, Forest, Global South, Multimedia, Time-invariant system, Renewable energy, Animal, Creative industries, Pharmaceutical industry

NEW YORK, May 9, 2022 /PRNewswire/ -- Today, the Ford Foundation released "Reimagine Recovery: a playbook for an equitable future" which captures how leaders and decision-makers can rethink and reshape social, economic, political and governance systems for a more just and equitable future at a pivotal moment for societal transformation. The three-part guide features critical lessons and offers urgent solutions from both global organizations fighting the pandemic's devastating effects firsthand and innovative business leaders seeking to better the way we work and live.

Key Points: 
  • In June 2020, Ford launched an unprecedented $1 billion social bond to help nonprofits weather the challenges presented by COVID-19.
  • In order to achieve this, we need to move from relief to recovery and beyond reform to reimagination," said Ford Foundation president Darren Walker.
  • "Reimagine Recovery takes a holistic look at the interrelated issues that we cannot ignore, and outlines solutions for change.
  • "Ownership Works is pleased to partner with the Ford Foundation as they chart a path for organizations across sectors to reimagine recovery for all."

CareTrust REIT Announces Election of New Directors

Retrieved on: 
Thursday, May 5, 2022
Nursing, Economy, Trust, Lawyer, Infection, Annual report, Urban Land Institute, Board of directors, COVID-19 vaccine, Lead, CSR, Risk, Forward-looking statement, Sustainability, Director, Company, NYSE, Drake University Law School, Tenant, Audit committee, SAN, REIT, U.S. Securities and Exchange Commission, Investment, Private Securities Litigation Reform Act, Dorsey & Whitney, Security (finance), World3 nonrenewable resource sector, Leadership, LLP, Lindquist & Vennum, Ownership, Financial compensation, Acquisition, Board, COVID-19, Nasdaq, LLC, GLOBE, Shoe, Drake University, Real estate, Management, U.S. Bancorp, Real estate investment trust, CenterSpace Software

SAN CLEMENTE, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- The Board of Directors of CareTrust REIT, Inc. (Nasdaq:CTRE) today announced that Careina D. Williams and Anne Olson have been elected as directors at the Companys annual shareholder meeting held on May 3, 2022.

Key Points: 
  • SAN CLEMENTE, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- The Board of Directors of CareTrust REIT, Inc. (Nasdaq:CTRE) today announced that Careina D. Williams and Anne Olson have been elected as directors at the Companys annual shareholder meeting held on May 3, 2022.
  • Anne brings a real-world, real-time perspective on REIT operations and other issues affecting public REITs, as she daily faces many of the same issues at Centerspace that we deal with at CareTrust, he added.
  • CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled nursing, seniors housing and other healthcare-related properties.
  • With a nationwide portfolio of long-term net-leased properties, and a growing portfolio of quality operators leasing them, CareTrust REIT is pursuing both external and organic growth opportunities across the United States.

Hyatt Is Remixing Hospitality With Planned Launch of Caption by Hyatt Lifestyle Brand in Memphis This Summer

Retrieved on: 
Monday, May 2, 2022
Residential Building & Real Estate, Retail, Commercial Building & Real Estate, Construction & Property, Other Communications, Other Travel, Communications, Lodging, Destinations, Travel, Restaurant, Bar, Vacation, Interior Design, Food, Beverage, Architecture, Other Construction & Property, Well, Share repurchase, Failure, JDV, Park, Restaurant, Exterior (topology), Internet, Environment, Danny Meyer, COVID-19 vaccine, Friends, SEC, IPhone, Apple Wallet, World, Company, NYSE, Earthquake, Beale Street, Wildfire, Unemployment, Industry, Pandemic, Heart, Alderbrook Resort & Spa, COVID-19 testing, ALG, Infection, Private Securities Litigation Reform Act, Flood, U.S. Securities and Exchange Commission, Policy, Caption, Vaccine, Tornado, Brookwater Golf and Spa Resort, Tsunami, Apple Leisure Group, Growth, Acquisition, Multimedia, Front Street, COVID-19, Mississippi River, Personality, Travel, Annual report, Trade, Apple Watch, Form 10-K, Pacific typhoon season, Coffee, Hotel, Interior design, Nightclub, Baking

Celebrating the launch of its newest lifestyle brand, Hyatt Hotels Corporation (NYSE: H) is proud to announce the introduction of the Caption by Hyatt brand with the planned summer 2022 opening of the 136-room Caption by Hyatt Beale Street Memphis in Tenn.

Key Points: 
  • Celebrating the launch of its newest lifestyle brand, Hyatt Hotels Corporation (NYSE: H) is proud to announce the introduction of the Caption by Hyatt brand with the planned summer 2022 opening of the 136-room Caption by Hyatt Beale Street Memphis in Tenn.
  • The Caption by Hyatt brand is also expected to grow in key global leisure markets through 2024, including Shanghai, Tokyo, and more.
  • Were thrilled to see the first Caption by Hyatt hotel come to life on vibrant Beale Street in Memphis.
  • Designed by HBG Design, Caption by Hyatt Beale Street Memphis will be integrated into the historic main building of Wm.

CVS Health Completes Rollout of Time Delay Safes in All of Its Nevada Pharmacies

Retrieved on: 
Friday, April 29, 2022
NYSE, Law enforcement, Time, Pharmacist, Pharmacy, CVS Health, Patient, General counsel, COVID-19, Organization, Practitioner, Technology, CVS, Partnership, Health, Conditional sentence, COVID-19 vaccine, Theft, Oxycodone, Heart, Water supply, Hydrocodone, CVS Pharmacy, Physician, Nursing, Narcotic, Environment, District, Safety, Personal care, Drug, Pharmaceutical industry, Target

WOONSOCKET, R.I., April 29, 2022 /PRNewswire/ -- As part of an ongoing commitment to support law enforcement and help build safer communities, CVS Health (NYSE: CVS) today announced the completed installation of time delay safe technology in all 97 Nevada CVS Pharmacy locations, including those in Target stores. The safes are anticipated to help prevent pharmacy robberies and the potential for associated diversion of controlled substance medications – including opioid medications such as oxycodone and hydrocodone – by electronically delaying the time it takes for pharmacy employees to open the safe. In addition, the safes are anticipated to benefit the safety and well-being of CVS Pharmacy customers and employees. 

Key Points: 
  • In addition, the safes are anticipated to benefit the safety and well-being of CVS Pharmacy customers and employees.
  • "The new security measures being implemented by CVS Health will help protect Nevadans," said Nevada Attorney General Aaron Ford.
  • CVS Health first implemented time delay safe technology in 2015 in CVS Pharmacy locations across Indianapolis, a city experiencing a high volume of pharmacy robberies at the time.
  • All CVS Pharmacy locations in Nevada display visible signage warning that time delay safes are in use to prevent on-demand access to controlled substance narcotics.

IAA Appoints Michael Sieger to Board of Directors

Retrieved on: 
Friday, April 29, 2022
Fleet Management, General Automotive, Technology, Automotive, Software, IAA, Progressive Corporation, BSEE, U.S. Securities and Exchange Commission, NYSE, LinkedIn, Sale, YouTube, LLC, Twitter, Myers, Risk, Leadership, Board of directors, Private Securities Litigation Reform Act, COVID-19, Progressive, Growth, O'Melveny & Myers, United Kingdom, Privacy, Company, University of Chicago, Security (finance), Marketing, COVID-19 vaccine, National Operating Committee on Standards for Athletic Equipment, Latham & Watkins, MBA, General manager, Board, Case Western Reserve University, University, Industry, Insurance, SEC, Electricity, Instagram, Electrical engineering, Management, Risk management, Facebook

IAA, Inc. (NYSE: IAA), a leading global marketplace connecting vehicle buyers and sellers, today announced that it has appointed Michael Sieger to its Board of Directors, effective immediately as of the conclusion of the Companys 2022 annual meeting of stockholders.

Key Points: 
  • IAA, Inc. (NYSE: IAA), a leading global marketplace connecting vehicle buyers and sellers, today announced that it has appointed Michael Sieger to its Board of Directors, effective immediately as of the conclusion of the Companys 2022 annual meeting of stockholders.
  • As a result of the appointment, IAAs Board will expand to 10 directors, 9 of whom are independent.
  • In addition, the IAA Board has formed an Operations Committee focused on driving operational performance.
  • We look forward to Mike joining the Board, said John Larson, Chairman of the Board of Directors of IAA.